Dietary calcium and dairy products modulate oxidative and inflammatory stress in mice and humans

Journal of Nutrition

Volumn 138, Issue 6, 2008, Pages 1047-1052

  Zemel, Michael B ^a   Sun, Xiaocun ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; AGOUTI PROTEIN; C REACTIVE PROTEIN; CALCIUM; CALCIUM CARBONATE; FATTY ACID BINDING PROTEIN; INTERLEUKIN 15; INTERLEUKIN 6; MALONALDEHYDE; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOSE TISSUE; ARTICLE; BLOOD LEVEL; CALCIUM INTAKE; CONTROLLED STUDY; DAIRY PRODUCT; DIETARY INTAKE; FOLLOW UP; HUMAN; INFLAMMATION; LOW CALORY DIET; MILK; NONHUMAN; OBESITY; OXIDATIVE STRESS; TRANSGENIC MOUSE;

AGOUTI; MUS; MUS MUSCULUS;

EID: 44449170432     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/138.6.1047     Document Type: Article

References (54)

1. Petrov V, Lijnen P. Modification of intracellular calcium and plasma renin by dietary calcium in men. Am J Hypertens. 1999;12:1217-24.
2. Rao RM, Yan Y, Wu Y. Dietary calcium reduces blood pressure, parathyroid hormone, and platelet cytosolic calcium responses in spontaneously hypertensive rats. Am J Hypertens. 1994;7:1052-7.
3. Zemel MB, Shi H, Greer B, Dirienzo D, Zemel PC. Regulation of adiposity by dietary calcium. FASEB J. 2000;14:1132-8.
4. 3 (OH)2-D3 regulation of adipokine expression. Obesity (Silver Spring). 2007;15:340-8.
5. Zemel MB. Nutritional and endocrine modulation of intracellular calcium: implications in obesity, insulin resistance and hypertension. Mol Cell Biochem. 1998;188:129-36.
6. Kim JH, Kiefer LL, Woychik RP, Wilkison WO, Truesdale A, Ittoop O, Willard D, Nichols J, Zemel MB. Agouti regulation of intracellular calcium: role of melanocortin receptors. Am J Physiol. 1997;272:E379-84.
7. Zemel MB, Moore JW, Moustaid N, Kim JH, Nichols JS, Blanchard SG, Parks DJ, Harris C, Lee FW, et al. Effects of a potent melanocortin agonist on the diabetic/obese phenotype in yellow mice. Int J Obes Relat Metab Disord. 1998;22:678-83.
8. Jones BH, Kim JH, Zemel MB, Woychik RP, Michaud EJ, Wilkison WO, Moustaid N. Upregulation of adipocyte metabolism by agouti protein: possible paracrine actions in yellow mouse obesity. Am J Physiol. 1996;270:E192-6.
9. Kim JH, Mynatt RL, Moore JW, Woychik RP, Moustaid N, Zemel MB. The effects of calcium channel blockade on agouti-induced obesity. FASEB J. 1996;10:1646-52.
10. Moustaid N, Sakamoto K, Clarke S, Beyer RS, Sul HS. Regulation of fatty acid synthase gene transcription. Sequences that confer a positive insulin effect and differentiation-dependent expression in 3T3-L1 preadipocytes are present in the 332 bp promoter. Biochem J. 1993;292:767-72.
11. Xue B, Greenberg AG, Kraemer FB, Zemel MB. Mechanism of intracellular calcium ([Ca21]i) inhibition of lipolysis in human adipocytes. FASEB J. 2001;15:2527-9.
12. Shi H, Norman AW, Okamura WH, Sen A, Zemel MB. 1alpha,25-dihydroxyvitamin D3 inhibits uncoupling protein 2 expression in human adipocytes. FASEB J. 2002;16:1808-10.
13. Sun X, Zemel MB. Role of uncoupling protein 2 (UCP2) expression and 1alpha, 25-dihydroxyvitamin D3 in modulating adipocyte apoptosis. FASEB J. 2004;18:1430-2.
14. Sun X, Morris K, Zemel MB. Microarray analysis of the effects of calcitriol and cortisone on human adipocyte gene expression. J Nutrigenet Nutrigenomics. 2008;1:30-48.
15. Sun X, Zemel MB. Calcium and dairy products inhibit weight and fat regain during ad libitum consumption following energy restriction in Ap2-agouti transgenic mice. J Nutr. 2004;134:3054-60.
16. Sun X, Zemel MB. Dietary calcium regulates ROS production in aP2-agouti transgenic mice on high-fat/high-sucrose diets. Int J Obes (Lond). 2006;30:1341-6.
17. Thompson WG, Rostad Holdman N, Janzow DJ, Slezak JM, Morris KL, Zemel MB. Effect of energy-reduced diets high in dairy products and fiber on weight loss in obese adults. Obes Res. 2005;13:1344-53.
18. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114:1752-61.
19. Atabek ME, Vatansev H, Erkul I. Oxidative stress in childhood obesity. J Pediatr Endocrinol Metab. 2004;17:1063-8.
20. Lin TK, Chen SD, Wang PW, Wei YH, Lee CF, Chen TL, Chuang YC, Tan TY, Chang KC, et al. Increased oxidative damage with altered antioxidative status in type 2 diabetic patients harboring the 16189 T to C variant of mitochondrial DNA. Ann N Y Acad Sci. 2005;1042:64-9.
21. Sonta T, Inoguchi T, Tsubouchi H, Sekiguchi N, Kobayashi K, Matsumoto S, Utsumi H, Nawata H. Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity. Free Radic Biol Med. 2004;37:115-23.
22. Sun X, Zemel MB. 1α, 25-Dihydroxyvitamin D3 modulation of reactive oxygen species production and cell proliferation in human and murine adipocytes. Obesity (Silver Spring). 2007;15:1944-53.
23. Zemel MB. The role of dairy foods in weight management. J Am Coll Nutr. 2005;24:S537-46.
24. Mynatt RL, Miltenberger RJ, Klebig ML, Zemel MB, Wilsinson JE, Wilkison WO, Woychik RP. Combined effects of insulin treatment and adipose tissue-specific agouti expression on the development of obesity. Proc Natl Acad Sci USA. 1997;94:919-22.
25. Klebig ML, Wilkinson JE, Geisler JG, Woychik RP. Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes, and yellow fur. Proc Natl Acad Sci USA. 1995;92:4728-32.
26. Yen TT, Gill AM, Grigeri LG, Barsh GS, Wolff GL. Obesity, diabetes, and neoplasia in yellow Avy/-mice: ectopic expression of the agouti gene. FASEB J. 1994;8:479-88.
27. Michaud EJ, Mynatt RL, Miltenberger RJ, Klebig ML, Wilkinson JE, Zemel MB, Wilkison WO, Woychik RP. Role of the agouti gene in obesity. J Endocrinol 1997;155:207-209.
28. Zemel MB, Mynatt RL, Dibling D. Synergism between diet-induced hyperinsulinemia and adipocyte-specific agouti expression. FASEB J. 1999;13:660-3.
29. Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A diet. J Nutr. 1993;123:1939-51.
30. Zemel MB, Richards J, Mathis S, Milstead A, Gebhardt L, Silva E. Dairy augmentation of total and central fat loss in obese subjects. Int J Obes (Lond). 2005;29:391-7.
31. Zemel MB, Richards J, Milstead A, Campbell P. Effects of calcium and dairy on body composition and weight loss in African-American adults. Obes Res. 2005;13:1218-25.
32. Zemel MB. Calcium and dairy modulation of obesity risk. Obes Res. 2005;13:192-3.
33. Jonsson JR, Game PA, Head RJ, Frewin DB. The expression and localization of the angiotensin-converting enzyme mRNA in human adipose tissue. Blood Press. 1994;3:72-5.
34. Crandall DL, Herzling HE, Saunders BD, Armellino DC, Kral JG. Distribution of angiotensin II receptors in rat and human adipocytes. J Lipid Res. 1994;35:1378-85.
35. Jones BH, Standridge MK, Taylor JW, Moustaid N. Angiotensinogen gene expression in adipose tissue: analysis of obese models and hormonal and nutritional control. Am J Physiol. 1997;273:R236-42.
36. Giachchetti G, Faloia E, Sardu C, Camilloni MA, Mariniello B, Gatti C, Garrapa GGM, Guerrieri M, Mantero F. Gene expression of angiotensinogen in adipose tissue of obese patients. Int J Obes Relat Metab Disord. 2000;24 Suppl 2:S142-3.
37. Engeli S, Schling P, Gorzelniak K, Boschmann M, Janke J, Ailhaud G, Teboul M, Massiéra F, Sharma AM. The adipose tissue renin-angiotensin- aldosterone system: role in the metabolic syndrome? Int J Biochem Cell Biol. 2003;35:807-25.
38. Darimont C, Vassaux G, Ailhaud G, Negrel R. Differentiation of preadipose cells: paracrine role of prostacyclin upon stimulation of adipose cells by angiotensin-II. Endocrinology. 1994;135:2030-6.
39. McIntyre M, Bohr DF, Dominiczak AF. Endothelial function in hypertension: the role of superoxide anion. Hypertension. 1999;34:539-45.
40. Ruiz-Ortega M, Ruperez M, Lorenzo O, Esteban V, Blanco J, Mezzano S, Egido J. Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int Suppl. 2002;82:S12-22.
41. Fukui T, Ishizaka N, Rajagopalan S, Laursen JB, Capers Q IV, Taylor WR, Harrison DG, de Leon H, Wilcox JN, et al. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res. 1997;80:45-51.
42. Hanna IR, Taniyama Y, Szocs K, Rocic P, Griendling KK. NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antioxid Redox Signal. 2002;4:899-914.
43. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, Griendling KK. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res. 2002;91:406-13.
44. Khan BV, Navalkar S, Khan QA, Rahman ST, Parthasarathy S. Irbesartan, an angiotensin type 1 receptor inhibitor, regulates the vascular oxidative state in patients with coronary artery disease. J Am Coll Cardiol. 2001;38:1662-7.
45. Napoli C, Sica V, de Nigris F, Pignalosa O, Condorelli M, Ignarro IJ, Liguori A. Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension. Am Heart J. 2004;148:e5.
46. Rennie MJ, Bohe J, Smith K, Wackerhage H, Greenhaff P. Branched-chain amino acids as fuels and anabolic signals in human muscle. J Nutr. 2006;136:S264-8.
47. Kobayashi H, Kato H, Hirabayashi Y, Murakami H, Suzuki H. Modulations of muscle protein metabolism by branched-chain amino acids in normal and muscle-atrophying rats. J Nutr. 2006;136:S234-6.
48. Sun X, Zemel MB. Leucine and calcium regulate fat metabolism and energy partitioning in murine adipocytes and muscle cells. Lipids. 2007;42:297-305.
49. Bouloumie A, Curat CA, Sengenes C, Lolmede K, Miranville A, Busse R. Role of macrophage tissue infiltration in metabolic diseases. Curr Opin Clin Nutr Metab Care. 2005;8:347-54.
50. Christiansen T, Richelsen B, Bruun JM. Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes (Lond). 2005;29:146-50.
51. Constant VA, Gagnon A, Landry A, Sorisky A. Macrophage-conditioned medium inhibits the differentiation of 3T3-L1 and human abdominal preadipocytes. Diabetologia. 2006;49:1402-11.
52. Permana PA, Menge C, Reaven PD. Macrophage-secreted factors induce adipocyte inflammation and insulin resistance. Biochem Biophys Res Commun. 2006;341:507-14.
53. Sun X, Zemel MB. Calcitriol and calcium regulate cytokine production and adipocyte-macrophage cross-talk. J Nutr Biochem. In press 2008.
54. Van Guilder GP, Hoetzer GL, Greiner JJ, Stauffer BL, DeSouza CA. Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults. Obesity (Silver Spring). 2006;14:2127-31.